Enhanced Recovery After Surgery (ERAS) Protocols in Cardiac Surgery: Impact on Opioid Consumption
Authors:
- Alexandra Othenin-GirardAOAlexandra Othenin-Girard
- Zied LtaiefZLZied Ltaief
- Mario Verdugo-MarcheseMVMario Verdugo-Marchese
- Luc LavanchyLLLuc Lavanchy
- Patrice VuadensPVPatrice Vuadens
- Anna NowackaANAnna Nowacka
- Ziyad GungaZGZiyad Gunga
- Valentine MellyVMValentine Melly
- Tamila AbdurashidovaTATamila Abdurashidova
- Caroline BotteauCBCaroline Botteau
- Marius HennemannMHMarius Hennemann
- Jérôme GrafJGJérôme Graf
Top Cited Papers
Open Access
- 6 March 2025
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (5) , 1768
Abstract
Background: Enhanced Recovery After Surgery (ERAS) protocols have been implemented in various surgical specialties to improve patient outcomes and reduce opioid consumption. In cardiac surgery, the traditionally high-dose opioid use is associated with prolonged ventilation, intensive care unit (ICU) stays, and opioid-related adverse drug events (ORADEs). This study evaluates the impact of an ERAS® Society-certified program on opioid consumption in patients undergoing elective cardiac surgery at Lausanne University Hospital. Methods: A retrospective, monocentric observational study was conducted comparing two patient cohorts: one treated with ERAS protocols (2023–2024) and a retrospective control group from 2019. Data were collected from the hospital’s electronic medical records and the ERAS program database. The primary outcome was total opioid consumption, measured intraoperatively and postoperatively (postoperative day (POD) 0–3). Secondary outcomes included pain control, length of stay, complications, and recovery parameters. Statistical analyses included multivariate logistic regression to identify factors associated with reduced opioid consumption. Results: Patients in the ERAS group demonstrated significantly lower total opioid consumption, whether intraoperatively (median sufentanil: 40 mcg vs. 51 mcg, p < 0.0001) or postoperatively (POD 0–3: p < 0.001). The ERAS group had faster extubation times, earlier mobilization and pain control with non-opioid analgesics, fewer complications, and shorter hospital stays (9 vs. 12 days, p < 0.001). Logistic regression identified fast-track extubation and absence of complications as strong predictors of reduced opioid use. Conclusions: The implementation of an ERAS protocol in cardiac surgery significantly reduces opioid consumption while enhancing recovery.Keywords
This publication has 42 references indexed in Scilit:
- The role of methadone in cardiac surgery for management of postoperative painBJA Open, 2024
- Guidelines on enhanced recovery after cardiac surgery under cardiopulmonary bypass or off-pumpAnaesthesia Critical Care & Pain Medicine, 2022
- Location and Patterns of Persistent Pain Following Cardiac SurgeryHeart, Lung and Circulation, 2021
- Development of Persistent Opioid Use After Cardiac SurgeryJAMA Cardiology, 2020
- Guidelines for Perioperative Care in Cardiac SurgeryJAMA Surgery, 2019
- Association of Opioid-Related Adverse Drug Events With Clinical and Cost Outcomes Among Surgical Patients in a Large Integrated Health Care Delivery SystemJAMA Surgery, 2018
- Enhanced Recovery After SurgeryJAMA Surgery, 2017
- Fast-track cardiac care for adult cardiac surgical patientsCochrane Database of Systematic Reviews, 2016
- A synthesis of oral morphine equivalents (OME) for opioid utilisation studiesPharmacoepidemiology and Drug Safety, 2015
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009